These variants have an important place in prognostic evaluation for future research and clinical applications, but in order to personalize the treatment, circulating TRAIL levels as prognostic biomarkers of the onset and progression of diabetes should be evaluated together with these results and the therapeutic potential of TRAIL should be investigated. Here, TNFSF10 is linked to diabetes mellitus.